# Role of Ascorbic Acid Infusion in Critically Ill Patients With Transfusion Related Acute Lung Injury

> **NCT04153487** · PHASE2 · COMPLETED · sponsor: **Damanhour University** · enrollment: 40 (actual)

## Conditions studied

- Acute Lung Injury, Transfusion Related

## Interventions

- **DRUG:** Ascorbic Acid Injectable Product
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04153487
- **Lead sponsor:** Damanhour University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-30
- **Primary completion:** 2021-07-16
- **Final completion:** 2021-07-16
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04153487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04153487, "Role of Ascorbic Acid Infusion in Critically Ill Patients With Transfusion Related Acute Lung Injury". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04153487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*